| Literature DB >> 25434699 |
Yoshinori Minami1, Takaaki Sasaki1, Hiroki Bochimoto2, Jun-Ichi Kawabe3, Satoshi Endo1, Yoshiki Hira2, Tsuyoshi Watanabe2, Shunsuke Okumura1, Naoyuki Hasebe4, Yoshinobu Ohsaki1.
Abstract
Prostaglandin I2 (PGI2) agonist has been reported to reduce tumor metastasis by modifying tumor angiogenesis; however, the mechanisms of how PGI2 affects the endothelial cells or pericytes in tumor vessel maturation are still unclear. The purpose of this study was to clarify the effects of PGI2 on tumor metastasis in a mouse lung metastasis model using Lewis lung carcinoma (LLC) cells. The mice were treated continuously with beraprost sodium (BPS), a PGI2 analog, for 3 weeks and then examined for lung metastases. The number and size of lung metastases were decreased significantly by BPS treatment. In addition, scanning electron microscopy and immunohistochemistry revealed that BPS increased the number of tumor‑associated pericytes and improved intratumor hypoxia. Collectively, this study suggests that BPS attenuated vascular functional maturation in metastatic tumors.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25434699 DOI: 10.3892/ijo.2014.2783
Source DB: PubMed Journal: Int J Oncol ISSN: 1019-6439 Impact factor: 5.650